Last edition
News about "Cutaneous T-Cell Lymphoma"
Knight Therapeutics Signs Latin America Deal for Mogamulizumab
Knight Therapeutics will seek regulatory approval and commercialise mogamulizumab in Brazil, Mexico, Colombia and Argentina under its agreement with Kyowa Kirin International.
Cutaneous T-Cell Lymphoma | 30/09/2026 | By News Bureau
Sobi-Innate Pharma Partnership Advances Lacutamab Phase 3 Study
The partnership between Sobi and Innate Pharma will support the TELLOMAK-3 confirmatory Phase 3 trial in CTCL and development of lacutamab in Sézary syndrome.
Cutaneous T-Cell Lymphoma | 18/09/2026 | By News Bureau
Sobi and Innate Pharma Partner to Advance Lacutamab in T-Cell Lymphoma
Sobi and Innate Pharma partners to advance lacutamab into the TELLOMAK-3 Phase 3 trial, supporting its potential accelerated approval in Sézary syndrome and future development across cutaneous T-cell lymphoma.
Cutaneous T-Cell Lymphoma | 10/08/2026 | By News Bureau | 151
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy